AI
WST icon

AXS Investments’s West Pharmaceutical WST Stock Holding History

AXS Investments’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-213
Closed -$75K – 428
2023
Q4 		$75K Sell
213
-27
-11% -$9.55K 0.02% 347
2023
Q3 		$90K Sell
240
-25
-9% -$9.67K 0.02% 304
2023
Q2 		$101K Buy
+265
New +$94.7K 0.03% 303
2021
Q2 		– Sell
-1,710
Closed -$482K – 182
2021
Q1 		$482K Buy
+1,710
New +$489K 0.17% 107

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

AXS Investments's WST Position: Q1 2024 in Review

AXS Investments sold out of West Pharmaceutical (WST) in Q1 2024, closing a stake of 213 shares — an estimated $75K sold.

AXS Investments first reported a position in WST in Q1 2021 and held it in 4 quarters. The position peaked at $482K in Q1 2021. 778 funds tracked by Wall St. Rank hold WST as of Q1 2024.

  • AXS Investments reported no remaining West Pharmaceutical position as of Q1 2024 after selling out during the quarter.
  • AXS Investments sold 213 West Pharmaceutical shares in Q1 2024, an estimated $75K.
  • AXS Investments first reported a position in West Pharmaceutical in Q1 2021 and held it in 4 quarters.
  • AXS Investments's West Pharmaceutical position peaked at $482K in Q1 2021.
  • 778 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2024.

Based on AXS Investments's 13F filing for Q1 2024, filed 13 May 2024.